Efficacy Study of an Interactive Robot for the Rehabilitation of the Upper Limb in Children With Cerebral Palsy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Cerebral Palsy (CP) is a major cause of impairments in child population. This disease justifies an intensive and prolonged multidisciplinary rehabilitation which can be optimised by robotics.
Our team has developed a robot designed to rehabilitate the child's upper limb. This robot allows the patient to perform active, passive, or assisted exercises.
This therapy is designed to promote motor development in children with CP. Its finality is to improve patients' quality of life and participation.
Several pilot studies evaluated the efficacy of robotic assisted therapy in children with CP but none RCT has been done.
Then, the aim of the study is to evaluate the efficacy of robotic-assisted therapy in children with cerebral palsy by evaluating the 3 fields of the ICF (International Classification of Functioning, Disability and Health) and performing a prospective randomized controlled single blind trial. Therefore, all patients will benefit from a classical rehabilitation as a basis. Furthermore, patients of the control and experimental groups will receive a supplement of classical rehabilitation and robotic-assisted therapy, respectively.
| Condition | Intervention |
|---|---|
|
Cerebral Palsy |
Other: Robotic-assisted therapy Other: Classical therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Study of the Effectiveness of an Interactive Robot for the Rehabilitation of the Upper Limb in Children With Cerebral Palsy by Evaluating the 3 Fields of the ICF: A Prospective, Randomized, Controlled, Simple Blind Study. |
- Kinematic [ Time Frame: Change from Baseline in Kinematic at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- Manual Ability Classification System [ Time Frame: Change from Baseline in manual ability at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- Quality of Upper Extremity Skills Test [ Time Frame: Change from Baseline in quality of upper extremity skills at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- Box and Block test [ Time Frame: Change from Baseline in dexterity at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- strength [ Time Frame: Change from Baseline in strength at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- Abilhand-Kids scale [ Time Frame: Change from Baseline in activity of daily living at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- Pediatric Evaluation of Disability Inventory [ Time Frame: Change from Baseline in activity of daily living at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
- MHAVIE [ Time Frame: Change from Baseline in parents' satisfaction of children activity daily living at an expected average of 3 months and 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 16 |
| Study Start Date: | September 2012 |
| Study Completion Date: | May 2013 |
| Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Experimental: Robotic-assisted therapy
All patients will receive a similar classical rehabilitation as a basis. the 10 patients of this group will receive a supplement of robotic-assisted therapy.
|
Other: Robotic-assisted therapy
This robotic device is designed to intensively rehabilitate the upper limb. Indeed, this robot allows the patient to perform a lot of active, passive, or assisted exercises. The level of assistance is determined and provided by the robot in function of the patient capacity.
Other: Classical therapy
conventional therapy will be performed by therapists specialized in neuro-pediatric rehabilitation
|
|
Active Comparator: Classical therapy
All patients will receive a similar classical rehabilitation as a basis. the 10 patients of this group will receive a supplement of classical rehabilitation.
|
Other: Classical therapy
conventional therapy will be performed by therapists specialized in neuro-pediatric rehabilitation
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 4 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Cerebral palsy (hemi, quadri or di-plegia)
- MACS > 1/5 (moderate to severe impairments)
Exclusion Criteria:
- Botulinum toxin injection in the upper limb muscles
- Intrathecal Baclofen for the upper limb spasticity
- an unstable clinical condition contraindicating the upper limb rehabilitation treatments
- cognitive disorders preventing the understanding of the instructions
- other neurological or orthopedic pathology affecting the upper limb.
Contacts and Locations| Belgium | |
| Institut royal de l'accueil du handicap moteur | |
| Brussel, Belgium, 1200 | |
| Principal Investigator: | Maxime Gilliaux, PhD student | Université Catholique de Louvain |
More Information
Publications:
| Responsible Party: | Lejeune, Professor, Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| ClinicalTrials.gov Identifier: | NCT01700153 History of Changes |
| Other Study ID Numbers: | IONS-Gilliaux-01 |
| Study First Received: | September 26, 2012 |
| Last Updated: | May 6, 2013 |
| Health Authority: | Belgium: Federal Agency for Medicinal Products and Health Products |
Keywords provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:
|
Robotic-assisted therapy cerebral palsy ICF |
Additional relevant MeSH terms:
|
Cerebral Palsy Paralysis Brain Damage, Chronic Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Neurologic Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013